Volume 87 Issue 22 | pp. 18-19
Issue Date: June 1, 2009

On The Map

With strategy and a bit of luck, Aspen has quickly established itself on the global pharma scene
Department: Business
Keywords: antiretrovirals, pharmaceuticals, generic

IN 2002, executives from a small drug company in South Africa flew to Paris on what they feared was a futile mission. The Aspen Pharmacare team arrived at the doorstep of Bristol-Myers Squibb (BMS), the maker of several HIV drugs, with their caps in one hand and a videocassette of an HIV clinic in the Eastern Cape, near the birthplace of Nelson Mandela, in the other. Their message was simple: Your . . .

To view the rest of this content, please log in with your ACS ID.



Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society